Vice President-Site GM
GSK
Greg has more than 20 years of experience in the biopharmaceutical industry spanning process development, MSAT, and Manufacturing across a wide array of modalities. In his current role, Greg is the Site Director for GSK’s multi-product clinical and commercial drug substance facility in Upper Merion, PA. Prior to GSK, Greg led the Global Vaccines and Biologics Commercialization organization at Merck and held roles of increasing responsibility at Amgen including head of their global Drug Substance Technology & Engineering organization. Greg holds an M.S in Biotechnology from the Johns Hopkins University.